Lonza acquires US CDMO Network von Merck KGaA
CDMO, bioconjugates, viral vectors · USAcarved out toLonza
advised by
- Buy-side
- BofA Securities
Lonza acquires five CDMO production sites in the USA with around 1,100 employees from Merck KGaA. The sites cover bioconjugates, payload linkers, viral vectors and lipid nanoparticles.
- Buyer
- Lonza
- Target
- US CDMO Network von Merck KGaA
- Seller
- Merck KGaA, Darmstadt
- Type
- Carve-out
- Sector
- CDMO, bioconjugates, viral vectors
- Country
- USA
- First reported
- 03/11/2026
- Buy-side
- BofA Securities, according to the source
- Source
- eqs-news.com
Deal-Radar no. 45-068 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Lonza
So far this is the only transaction by Lonza published in the Deal-Radar. New deals are added every Monday.
Acquisitions abroad in Week 45/2026
All deals in November 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 3 November 2026.